Column Capital Advisors, LLC Ptc Therapeutics, Inc. Transaction History
Column Capital Advisors, LLC
- $1.92 Billion
- Q3 2023
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
198Shares Held
83.7MCall Options Held
192KPut Options Held
129K-
Vanguard Group Inc Valley Forge, PA9.37MShares$290 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.9MShares$276 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.57MShares$235 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.42MShares$230 Million3.47% of portfolio
-
Armistice Capital, LLC New York, NY6.76MShares$210 Million2.68% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.22B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...